BMY - BRISTOL MYERS SQUIBB CO
59.71
-0.220 -0.368%
Share volume: 12,496,732
Last Updated: Wed 05 Feb 2025 10:00:00 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.25%
PREVIOUS CLOSE
CHG
CHG%
$59.93
0.59
0.01%
View ratios
| Fiscal Date | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-03-31 | 2024-06-30 | 2024-06-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q1 2024 | Q2 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 2023-07-27 | 2023-10-26 | 2024-02-13 | 2024-04-25 | 2024-04-25 | 2024-07-26 | 2024-07-26 | 2024-10-31 | |
| Assets | |||||||||
| Total Assets | 93.489 B | 91.263 B | 95.159 B | 99.031 B | 99.031 B | 94.646 B | 94.646 B | 93.670 B | |
| Current Assets | 28.074 B | 27.632 B | 31.770 B | 28.669 B | 28.669 B | 26.890 B | 26.890 B | 28.075 B | |
| Inventories | 2.364 B | 2.436 B | 2.662 B | 2.985 B | 2.985 B | 3.077 B | 3.077 B | 3.332 B | |
| Other Current Assets | 6.815 B | 7.153 B | 5.852 B | 5.567 B | 5.565 B | 5.737 B | 5.735 B | 5.623 B | |
| Short Term Investments | 6.815 B | 7.153 B | 5.852 B | 340.000 M | 5.565 B | 360.000 M | 5.735 B | 204.000 M | |
| Total Receivables | 10.112 B | 10.304 B | 10.921 B | 0.000 | 10.447 B | 0.000 | 11.423 B | 0.000 | |
| Current Cash | 8.730 B | 7.685 B | 12.280 B | 9.330 B | 9.670 B | 6.293 B | 6.653 B | 7.890 B | |
| Total Non-current Assets | 65.415 B | 63.631 B | 63.389 B | 367.000 M | 70.362 B | 357.000 M | 67.756 B | 324.000 M | |
| Property Plant Equipment | 6.355 B | 6.481 B | 6.646 B | 6.750 B | 6.750 B | 6.845 B | 6.845 B | 6.903 B | |
| Other Assets | 1.757 B | 2.290 B | 2.281 B | 63.612 B | 2.727 B | 60.911 B | 2.754 B | 58.692 B | |
| Intangible Assets | 31.303 B | 28.950 B | 27.072 B | 0.000 | 32.760 B | 0.000 | 29.428 B | 0.000 | |
| Goodwill | 21.163 B | 21.147 B | 21.169 B | 0.000 | 21.738 B | 0.000 | 21.732 B | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 93.489 B | 91.263 B | 95.159 B | 99.031 B | 99.031 B | 94.646 B | 94.646 B | 93.670 B | |
| Total liabilities | 61.516 B | 62.265 B | 65.729 B | 82.483 B | 82.541 B | 77.577 B | 77.631 B | 76.470 B | |
| Total current liabilities | 20.150 B | 23.462 B | 22.262 B | 25.822 B | 25.822 B | 23.265 B | 23.265 B | 22.638 B | |
| Accounts Payable | 3.069 B | 2.813 B | 3.259 B | 3.539 B | 3.539 B | 3.751 B | 3.751 B | 3.469 B | |
| Other liabilities | 4.162 B | 4.306 B | 4.464 B | 6.732 B | 4.701 B | 4.993 B | 3.088 B | 4.728 B | |
| Current long term debt | 3.020 B | 5.467 B | 3.119 B | 0.000 | 6.190 B | 0.000 | 3.531 B | 0.000 | |
| Long term debt | 34.656 B | 32.137 B | 36.653 B | 49.487 B | 49.487 B | 48.858 B | 48.858 B | 48.674 B | |
| Other liabilities | 4.162 B | 4.306 B | 4.464 B | 6.732 B | 4.701 B | 4.993 B | 3.088 B | 4.728 B | |
| Minority interest | 57.000 M | 64.000 M | 55.000 M | 0.000 | 58.000 M | 0.000 | 54.000 M | 0.000 | |
| Total Shareholder equity | 31.973 B | 28.998 B | 29.430 B | 16.490 B | 16.490 B | 17.015 B | 17.015 B | 17.142 B | |
| Common stock | 2.093 B | 2.057 B | 2.027 B | 45.947 B | 2.023 B | 46.058 B | 2.027 B | 46.188 B | |
| Retained earnings | 27.449 B | 28.218 B | 28.766 B | 15.640 B | 15.640 B | 16.103 B | 16.103 B | 16.097 B |